Tirzepatide (Dual GIP/GLP-1 Receptor Agonist)
Select Dosage
Prices shown are approximate and may vary. Click vendor links for current pricing. Links may be affiliate links — we may earn a small commission at no extra cost to you. Prices last checked Mar 29, 2026.
Current best: $109.99 for 5mg. Set a target below this to get notified.
Tirzepatide is a dual GIP and GLP-1 receptor agonist that activates both incretin pathways. It enhances glucose-dependent insulin secretion, suppresses glucagon, delays gastric emptying, increases satiety, enhances fat metabolism through GIP activation, improves insulin sensitivity, and acts centrally to reduce food intake.
| Level | Amount | Frequency | Timing |
|---|---|---|---|
| Beginner | 2.5 mg | Once weekly | Initial dose for 4 weeks |
| Standard | 5-10 mg | Once weekly | Titrate by 2.5mg every 4 weeks |
| Advanced | 15 mg | Once weekly | Maximum dose after gradual titration |
Long-term use under medical supervision
Approximately 5 days
Pre-filled pens or reconstitute powder with bacteriostatic water
Refrigerate at 36-46°F
Refrigerate at 36-46°F, use within 28 days
Explore peer-reviewed studies and clinical research on Tirzepatide
Peer-reviewed medical research
Active and completed clinical trials
Academic papers and citations
Evidence-based supplement analysis
Research Disclaimer: These links lead to external research databases. Always consult with a qualified healthcare provider before making decisions based on research literature.
This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment recommendation. Consult a licensed healthcare professional before using any peptide. BioProtocol does not sell peptides or pharmaceutical products.